, [opzi-Bo], cancer is approved as a treatment for malignant skin cancer at the beginning and then was expanded to lung cancer and kidney cancer patients by new type cells to attack cancer. Latest report opened

11, the Ministry of health experts, new malignant lymphoma, Hodgkin's lymphoma cancer patients who are effectiveness are acceptable and should be approved. Consolidated policy to approve close patients number of illnesses in the country approximately 2000 people and the Ministry of health received a report of this, an estimated op Zeb remedy for illness as well.

And as more patients is estimated to cost approximately 35 million yen and over

opzi-Bo lung cancer cases, 60 kg male patients for one year to use your to squeeze the nation's finances are concerned. For this reason, consider limiting use to patients with a significant reduction in the price or the effects can be expected, such as.